ViewRay, Inc.
VRAY
VRAY was delisted on the 25th of July, 2023.
6 hedge funds and large institutions have $102M invested in ViewRay, Inc. in 2016 Q1 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$34.4M |
| 2 |
O
OrbiMed
New York
|
+$34.4M |
| 3 |
AC
Aisling Capital
New York
|
+$32.1M |
| 4 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
+$821K |
| 5 |
BSW
Buckingham Strategic Wealth
Clayton,
Missouri
|
+$215K |
Top Sellers
VRAY Hedge Fund Activity: Q1 2016 in Review
6 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in ViewRay, Inc. (VRAY) for Q1 2016, worth a combined $102M.
Buyers outnumbered sellers: 6 funds opened new VRAY positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $34.4M.
- 6 institutional investors held ViewRay, Inc. (VRAY) as of Q1 2016, up from 0 in Q4 2015.
- Funds reported $102M of ViewRay, Inc. stock for Q1 2016.
- 6 funds opened new ViewRay, Inc. positions in Q1 2016 and 0 closed out, a net change of +6 holders.
- The largest ViewRay, Inc. buyer in Q1 2016 was Fidelity Investments, an estimated $34.4M added.
Based on aggregated 13F filings for Q1 2016.